Immune Cells Mutate to Escape Tolerance and Drive Thyroid Autoimmune Disease

This groundbreaking study reveals how immune cells escape tolerance to cause autoimmune disease. Using cutting-edge NanoSeq technology, researchers analyzed thyroid tissue from patients with autoimmune thyroid disease to test a long-standing hypothesis about somatic mutations driving autoimmunity.

The team discovered that B cells convergently acquire loss-of-function mutations in critical immune checkpoint genes, particularly TNFRSF14 (HVEM) and CD274 (PD-L1). In highly inflamed biopsies, they detected tens to hundreds of independent mutant clones, with some carrying 4-6 driver mutations and widespread biallelic loss of TNFRSF14.

Using multiple advanced techniques including laser microdissection, spatial transcriptomics, and single-nucleus DNA sequencing, researchers confirmed these mutations occur in B cells and that some clones are self-reactive. While each mutant clone represents less than 1% of cells, collectively they constitute a substantial fraction of B cells with driver mutations.

This research provides the first comprehensive evidence for polyclonal somatic evolution in autoimmune disease, where multiple independent clones acquire mutations that allow them to bypass immune tolerance checkpoints. The findings offer new insights into autoimmune disease mechanisms and could inform future therapeutic strategies targeting these mutant cell populations.